NCT04445454View on ClinicalTrials.gov

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Coronavirus Infection
Interventions
BIOLOGICAL

Mesenchymal stromal cells

Bone marrow collection and MSC expansion cultures will be carried out at the Laboratory of Cell and Gene Therapy (LTCG) at the University of Liège as described in IMPD and its SOPs.

Trial Locations (1)

4000

RECRUITING

CHU de Liège, Liège

All Listed Sponsors
lead

University of Liege

OTHER